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This thesis presents research in the field of microelectromechanical systems and 
specifically in the area of microneedle-based transdermal skin fluid extraction and 
drug delivery. The objective of this thesis is to highlight the potential role of 
microneedles in achieving painless transdermal skin biofluid extraction and drug 
delivery of macromolecular drugs across the skin barrier. The work represents the 
design and fabrication of silicon out-of-plane and in-plane microneedles and an 
innovative double-side Deep Reactive Ion Etching (DRIE) approach was presented for 
producing hollow silicon microneedle arrays for transdermal biological fluid 
extraction. The solid silicon out-of-plane microneedles are fabricated from a single 
side polished wafer whereas the hollow out-of-plane microneedles are fabricated from 
a double side polished wafer to a shank height of 200-300 μm with 300 μm center-to-
center spacing. The single-step Bosch DRIE is performed for “in-plane” silicon 
microneedles to simultaneously etch the needle shaft (parallel to silicon substrate, etch 
through the wafer) and the narrow trenches as open capillary fluidic channels (partly 
etched into the wafer), taking advantage of the aspect-ratio dependent DRIE etching. 
Furthermore, the double-sided two stage DRIE is performed to etch the open trenches 
on the backside of wafer and then the needle shaft on the front side. The in-plane 
needles have the advantages of making long needles up to 2 mm. Moreover, the in 
vivo testing results are provided as well. 
In this thesis, different microfabrication techniques are investigated, developed, 
optimized, and applied in the fabrication process. The first chapter conveys an 
overview of nanotechnology, nano-/microfabrication and their role in medicine. The 
second chapter illustrates an introduction to transdermal drug delivery and 
extraction. Furthermore, the fundamental background of skin structure and interstitial 
fluid (ISF) is introduced as well. Device fabrication tools and techniques are shown in 
chapter three. The fourth chapter presents a detailed literature review of microneedles 
in terms of its general concepts, structures, materials and integrated fluidic system. 
Eventually, Chapter 5 introduces the details of our method to fabricate solid and 
hollow silicon microneedle arrays step by step. SEM images and in vivo testing results 
confirm that silicon microneedle both out-of-plane and in-plane arrays are not only 
sharp enough to penetrate the stratum corneum but also robust enough to extract ISF 
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“I think it's much more interesting to live not knowing than to have answers which might be wrong.” 






This chapter brings an overview of importance of nanotechnology over the years, 
especially nanotechnology in medicine and MEMS for biomedical applications. 
Furthermore, the fundamental concept of nano-/microfabrication is introduced as 
well. 
1.1 Introduction to nanotechnology (nano-/microfabrication) 
The English physicist and chemist John Dalton initially proposed the logical 
hypothesis of the atom two hundred years ago. From that point forward we have seen 
scientific experts come to comprehend the components and their associations, we have 
seen engineers make and utilize new materials to enhance our lives, we have seen 
physicists show that even atoms are separable, and we have seen warriors release the 
intensity of the atomic nuclear. In these two centuries we have amassed a tremendous 
comprehension of and used an expanding power over the fundamental units of 
matter. 
Today, in the youthful field of nanotechnology, researchers and engineers are taking 
control of atoms and molecules separately, controlling them and putting them to use 
with an uncommon level of exactness. Expression of the guarantee of nanotechnology 
is spreading quickly, and the air is thick with news of nanotech achievements. 
Governments and organizations are putting billions of dollars in nanotechnology 
R&D, and political partnerships and fight lines are beginning to frame. Open attention 
to nanotech is plainly on the ascent, as well, somewhat in light of the fact that 
references to it are ending up increasingly regular in mainstream culture — with 
appearances in motion pictures (like The Hulk and The Tuxedo), books (counting a 




Gear Solid" arrangement), and TV (most strikingly in different manifestations of Star 
Trek). 
"Everything, when miniaturized to the sub-100-nanometer scale, has new properties, 
regardless of what it is," says Chad Mirkin, professor of chemistry at Northwestern 
University.  
Nanotechnology is the ability to individual atoms and molecules to create 
nanostructured materials and submicron objects that have applications in reality. 
Nanotechnology includes the generation and use of physical, chemical and biological 
frameworks at scales extending from individual atoms or molecules to around 100 
nanometers, and additionally the mix of the subsequent nanostructures into bigger 
frameworks. 
Nanofabrication is the design and manufacture of devices with dimensions measured 
in nanometer. A nanometer is one billionth of a meter. The prefix “nano-” comes from 
the Greek word nanos, meaning dwarf. (Scientists originally used the prefix just to 
indicate “very small,” as in “nanoplankton,” but it now means one-billionth, just as 
“milli-” means one-thousandth, and “micro-” means one-millionth). Figure 1.1 gives 
a feeling for the ‘nano world’, which is populated by atoms, molecules, and molecular 




Figure 1.1 From the ‘real’ to the nanoworld. Figure adapted from the Office of Technology 
Assessment [5]. 
As far back as the creation of the transistor in 1947, and later the reconciliation of every 
electronic segment in a ‘single chip', scaling down of these gadgets has been a 
continuous essential process. The component size of coordinated circuits has 
contracted by a relatively consistent rate of about 30% at regular intervals throughout 
the previous 15 years. This trend is known as Moore’s Law (Fig 1.2). The transistor 




while the storage capacity of dynamic random access memory (DRAM) chips has 
increased with a factor of four every three years. It enabled faster circuits, more 
complex designs, and more economical production processes. Spurred to continue 
this miniaturization trend, researchers continue to develop novel processes with 
improved quality [1]. It is expected that minimum dimensions of integrated circuits 
will continue to shrink at this rate over the coming decade. This can be seen from the 
current ‘roadmap’ [2] of the future for the semiconductor industry (table 1.1) [4].  
Figure 1.2 The number of transistors on integrated circuit chips [3]. 
Table 1.1 The overall roadmap technology characteristics [4]. 
In another reality where innovation is developing at a pace a lot higher than any 
purpose of time in written history, nanoengineering is pushing the limits of regular 




market and enjoying commercial success. After the innovation of the scanning 
tunneling microscope (STM) in 1980 by Gerd Binnig and Heinrich Rohrer at IBM 
Zurich, which also earned them the Nobel prize in physics in 1986, nanotechnology 
picked up fast. The development of STM was a precursor to the development of 
atomic force microscope (AFM) which ultimately allowed scientists to see the 
materials at unprecedentedly small scales. We have made considerable progress since 
the 1980s and the time is immaculate to audit a portion of the key nanotechnology 
improvements in STEM fields. The different phases of improvement have been 
condensed in the following Table 1.2 [10].  
Table 1.2 Different stages of development in nanotechnology [10]. 
In parallel, developments in the territory of microfabrication have made an 
extraordinary open door for assembling micron-sized structures [6]. In order to realize 
diverse novel applications with ultimate precision and high efficiency, various 
nano/microfabrication techniques are carried out in research area, which can be 




down approaches are good for producing structures with long-range order and for 
making macroscopic connections, while bottom-up approaches are best suited for 
assembly and establishing short-range order at nanoscale dimensions. Schematic 
representation of the formation of nanostructures via the top-down and bottom-up 
approaches (a) is shown in Fig 1.3 [7]. In top down fabrication approach (b), a tapered 
probe, manipulated by a macroscopic machine, allows “writing” small features by 
scratching the probe apex on a soft polymer surface. Notice the removed material 
disperses on the sides of the created grooves. In bottom-up fabrication approach (c), 
example of self-assembling set to occur on previously chemically functionalized 
surfaces; chemisorption happens due to interactions between adsorbing molecules 
and specific sites on the substrate. The resulting nano-electronics material emerges 





As one of the crucial and basic systems in microfabrication, optical lithography is 
broadly connected and created from the fabrication of integrated circuits to 
microelectromechanical systems (MEMS). Lithography strategies will be presented in 
detail in chapter 3.  
Figure 1.3 Schematic diagram of top-down and bottom-up approach. [(b) Image attained 
at Portland State University, Portland, Oregon, USA; courtesy of Rodolfo Fernandez. c) Image 
courtesy of Dr. Hiroyuki Sugimura, Nanoscopic Surface Architecture Laboratory, Department 
of Materials Science and Engineering Kyoto University, Japan.] 
1.2 Nanotechnology in medicine 
Countless applications of nanotechnologies are currently opening up. 




will have a wide range of applications from monitoring the pollution in the 
environment, the freshness of food, or the stresses in a building or a vehicle. Uses of 
nanotechnologies in medicine are particularly encouraging in the more extended 
term. These can be expected to enable drug delivery targeted at specific sites in the 
body so that, for example, chemotherapy is less invasive. Nanotechnology is being 
used for detection, diagnostics, therapeutics and monitoring. Subjects like 
nanotechnology put together imaging technologies and lab-on-a-chip point of care 
diagnostics, advanced nano-bio-sensor technologies, implantable nano sensors, nano 
arrays for advanced diagnostics and therapy, invasive therapy technologies and 
cellular based therapy. 
 
1.2.1 Biomedical application of MEMS 
Micro-Electro-Mechanical Systems (MEMS) are a class of miniature devices and 
systems fabricated by micromachining processes. MEMS innovation is a forerunner to 
the moderately increasingly well-known field of nanotechnology, which alludes to 
science, designing and innovation beneath 100 nm down to the atomic scale. This 
miniaturization ability has enabled MEMS to be applied in many areas of biology, 
medicine, and biomedical engineering – a field generally referred to as BioMEMS [14]. 
The field of microelectromechanical system was invented initially by the 
microfabrication techniques for a variety of applications such as electronics, sensors, 
actuators [11,12,13]. Models incorporate basic sensors utilized amid medical 
procedure, long-term sensors for prosthetic gadgets, and exceedingly modern sensor 




with small size (7.3 mm3) MEMS microphone suitable for hearing-aid applications 
[15].  
Figure 1.4 MEMS microphone [15] (Source: http://www.analog.com/). 
BioMEMS also give numerous opportunities for improved drug delivery: low-dose 
vaccinations and painless transdermal drug delivery are possible through precisely 
fabricated microneedles which penetrates into the skin's barrier layer without 












Transdermal Drug Delivery and Biofluid Extraction 
Transdermal drug delivery means that a medicinal compound is delivered across the 
skin—the dermis—for subsequent systemic distribution. Hence, strictly this does not 
only include the more commonly understood “patch”, but also traditional 
subcutaneous administration (a subcutaneous injection is administered as a bolus into 
the subcutis, the layer of skin directly below the dermis and epidermis, collectively 
referred to as the cutis) by means of a hypodermic needle and a syringe. With the 
increasing need for non-invasive biological fluid sampling and real time physiological 
monitoring, interest in exploring different methods to extract dermal interstitial fluid 
(ISF) has grown in recent years. This chapter demonstrates an overview of 
transdermal drug delivery, the fundamental concept of human skin anatomy and skin 
interstitial fluid (ISF). 
2.1 Transdermal drug delivery 
Transdermal therapeutic systems are defined as self-contained, self-discrete dosage 
forms, which when applied to the intact skin deliver the drug at a controlled rate to 
the systemic circulation. A straightforward patch sticks to the skin like a glue wrap, 
which uses detached dispersion of medications over the skin as the conveyance 
component. Regular to all strategies for transdermal drug delivery, by this expansive 
definition, the medication goes through an artificial route into the body. The principle 
preferred standpoint of this methodology is that the medication goes into the body 
undistorted without going through the body’s various defense systems. This method 
relies on the transport of drugs across the skin into the blood stream. The structure 
and properties of the skin are important factors for this method of administration. 
Transdermal delivery offers to an alluring option to oral delivery of medications and 




States in 1979, the first transdermal system for foundational delivery of scopolamine 
for three days to treat motion sickness was approved. After about 10 years, nicotine 
patches turned into the principal transdermal blockbuster, raising the profile of 
transdermal delivery in medicine. Today, there are 19 transdermal delivery systems 
for such medications as estradiol, fentanyl, lidocaine and testosterone; mix patches 
containing more than one medication for contraception and hormone substitution; 
and iontophoretic and ultrasonic delivery systems for the absence of pain. Somewhere 
between 1979 and 2002, another fix was affirmed every 2.2 years. In the course of 
recent years (2003– 2007), that rate has dramatically multiplied to another transdermal 
delivery framework every 7.5 months. It is evaluated that more than one billion 
transdermal patches are right now produced every year [23]. Table 2.1 shows 
cumulative number of transdermal drugs approved by the FDA since the first 
approval in 1979 [25].  




There are many drawbacks that came out gradually for oral administration of drugs 
and applying transdermal patches to deliver drugs across the skin became an 
attractive approach for the patients who are suffering painful injection but 
transdermal delivery, which relies on drugs passively diffusing across the skin is 
severely hindered by the low permeability of the outer skin. To increase permeability 
and reduce the pain simultaneously, the idea of combining the benefits of needle 
injection and transdermal patches was brought out, resulting in the creation of the 
microneedle concept which can be used for both drug delivery and extraction of 
biofluid for sampling.  
2.2 Skin as a barrier 
The skin is the largest organ of the body, with a total area of about 20 square feet. The 
skin protects us from entry of foreign elements but it is also a vital route for drug 
delivery and biofluid extraction. The human skin can be categorized in three primary 
layers: the topmost layer is epidermis, the layer underneath that is the dermis, and the 
deepest layer is hypodermis. It is epidermis layer that is optimally targeted for 
interstitial fluid extraction-superficial enough to be painless. The thickness of the 
epidermis layer is approximately 50-150 μm [18]. The two major layers of concern in 
the epidermis are the Stratum Corneum (SC) and the stratum spinosum. The topmost 
layer of the skin, which is what is exposed to the outside environment of the body, is 
the stratum corneum also called as horny layer and is the rate limiting barrier that 
restricts the inward and outward movement of chemical substances [17]. The stratum 
corneum is followed by two very thin layers called the stratum lucidum and the 
stratum granulosum. These layers are followed by the relatively thick stratum 
spinosum, the other primary layer of the epidermis. Between this layer and the 
dermis, which is the secondary layer of the skin after the epidermis, lies a thin 
separating layer called the stratum basale. The thickness of these layers will vary 




corneum is less than 40 μm where the thickness of the epidermis is between 0.2 and 
0.3 mm [19]. Figure 2.1 shows the cross-sectional illustration of human skin. 
Figure 2.1 Cross-section of human skin [20]. 
2.2.1 Thickness of stratum corneum 
A microneedle must be structured with the capacity to cut the skin effectively. This 
incorporates having a moderately sharp tip and a needle with a fairly high aspect ratio 
(the proportion of height to base length) and also a lumen (the inside space of a tubular 
structure, such as an artery or intesine) situated accurately so it doesn’t plug up amid 
skin penetration. Drug penetration across the stratum corneum is limited primarily 
by the lipids organized in bilayer structures [26]. Understanding the distinctive layers 
of the skin will empower better plan and design of microneedle for progressively 




corneum and the entire epidermis at different regions of a grown-up body are shown 
in the table 2.2.  
Table 2.2 Tabulated thickness for the human epidermis and the stratum corneum at various 
body location [27]. 
2.2.2 ISF 
Finding and observing of infection is regularly done by estimating biofluids found in 
blood, urine, spit, and other natural liquids. Another rich wellspring of biomarkers is 
the interstitial liquid that encompasses cells and tissues in the body, yet trouble in 
getting to this liquid has constrained its utilization in research and prescription. We 
conducted in vivo tests with experimental studies coupled with theoretical modeling 
to design microneedles that cut into the superficial layers of skin, and in this manner 
empower withdrawal of interstitial liquid through micro channels in a simple, 
straightforward non invasive manner. Researchers can access interstitial fluid using 
these microneedles to advance discovery of novel biomarkers and help doctors to use 









Device Fabrication Tools and Techniques 
The fabrication of out-of-plane and in-plane microneedles is explored and developed 
by utilizing microfabrication techniques. This chapter represents three key procedures 
explicitly utilized in the microneedle fabrication process which are photolithography, 
wet etch, and dry etch. 
3.1 Photolithography 
Photolithography is a staple of the microfabrication business. Developed in 1959, 
photolithography uses optical radiation to image the mask on a silicon wafer using 
photoresist layers. [29,30]. In general, photoresist, a photosensitive material, has two 
types, positive and negative. Upon exposure, the positive photoresist becomes more 
soluble. On the contrary, the negative photoresist becomes less soluble after exposure. 
The transfer of the pattern on the mask is done by the exposure process onto the 
photoresist. The patterns on a mask can be created down to ten of nanometers in size 
[30]. A simple representation of basic steps of photolithography is shown in Fig. 3.1. 
And in Fig. 3.2, the mechanism of positive and negative photoresist upon UV exposure 
is illustrated.  




Figure 3.2 Positive and negative photoresist (source: wikipaedia). 
As shown in Fig. 3.2, A mask with desired pattern needs to be created first. With spin-
coating the substrate with a photoresist the photolithography process starts. Prior to 
this application of liquid form of photoresist, usually an adhesion promoter such as 
hexamethyldisilazane (HMDS) is spun on the wafer. The thickness of the photoresist 
depends on the spinning speed and photoresist viscosity and the thickness is typically 
in the range 0.5–2.5μm. In order to remove the solvents from the resist and improve 
adhesion a soft baking process is performed for 5 to 30 minutes at 60o to 120o. After 
this, the photomask with the desired structural feature which was prepared before is 
well positioned above the photoresist using a mask aligner, then UV light travels 
through and focuses on the photoresist layer that is going to be soluble or insoluble 




development, the defined pattern will act as a barrier to protect the underlying film 
from wet or dry etching in the following process. Ultimately, the pattern is transferred 
from a photomask to the substrate successfully. Fig 3.3 shows the picture of a 
lithography system we used at the University of Waterloo for alignment and UV 
exposure of resist-coated wafers. 
Figure 3.3 MA/BA6 Mask Aligner (Courtesy to SUSS MicroTec). 
In our project, we also used another method for pattern transferring, which is called 
maskless lithography that directly transfers the information onto the substrate by laser 
writing, without utilizing an intermediate photomask. Maskless lithography offers 
topside alignment and backside alignment with high accuracy. For this purpose, we 
used Heidelberg MLA150 maskless aligner for pattern transfer. Another advantage of 
using MLA150 maskless aligner is that it can expose an area of 100 x 100 mm² with 
structures as small as 1 micron in less than 100 minutes – independent of number of 
structures within this area. Alignment in multi-layer applications is achieved within 




layer alignment accuracy is better than 500 nm. Fig 3.4 shows the Heidelberg MLA150 
maskless aligner in Quantum Nano Fab (QNF) we used. 
Figure 3.4 Heidelberg MLA150 maskless aligner (source: 
https://www.himt.de/index.php/maskless-write-lasers.html) 
Photolithography is a key step to transfer the pattern we designed to photoresist 






Etching is another fabrication step that is of fundamental importance to both VLSI 
processes and micro/nanofabrication. To selectively remove layers from the surface of 
a wafer resulting in desired patterns, etching is a critically essential process. The wafer 
is protected from the etchant by the photoresist that has been patterned using 
lithography acting as a masking material. It is often utilized in the microfabrication 
processes of semiconductor devices for the needs of wafer planarization, isolation, and 
cleaning. 
There are several important metrics in the etching process such as uniformity, etching 
rate, selectivity, anisotropy and undercut. Selectivity is the degree to which the etchant 
can differentiate between the masking layer and the layer to be etched. Directionality 
has to do with the etch profile under the mask [31]. Another critical parameter in the 
etching process is anisotropy or isotropy. Figure 3.2.1 shows the difference between 
isotropic and anisotropic etching.  
Figure 3.5 Schematic of isotropic, anisotropic and completely anisotropic etching [ source: 
http://www.vlsi-expert.com/2014/07/effect-of-etching-process_28.html] 
From Fig 3.5 we can see that, the etchant attacks the material in all directions at the 
same rate, hence creating a semicircular profile under the mask in an isotropic etch. In 
contrast, in an anisotropic etch, the dissolution rate depends on specific directions and 
straight side-walls or other noncircular profiles can be obtained.  
Etching process can also be categorized by two fundamental techniques based on the 




In this chapter, using this classification different wet etching processes will be 
discussed followed by dry etching techniques.  
3.2.1 Wet etching 
The fundamental concept of wet etching is the conversion of solid materials into liquid 
compounds using different chemical solutions. These processes are usually done by 
dipping the substrate in the chemical solution or the substrate is sprayed by the 
solution. In general, a wet etching procedure includes one or more chemical reactions 
that eat the original reactants and bring new species. In wet etching, the selectivity is 
generally very high because the individual film can adapt the used chemicals very 
precisely.  
A fundamental wet etching process entails three basic stages: 1) diffusion of the 
etchant to the surface; 2) the reaction between the liquid etchant and the material being 
etched away; and 3) diffusion of the reaction byproducts from the reacted surface. In 
Fig 3.6. the simple mechanisms of wet etching has shown. Wet etching is usually 








Figure 3.6 Three basic steps of wet etching. 
reaction 
Materials to be etched 
Diffusion towards surface Diffusion away from surface 
Surface diffusion 





3.2.1.1  Isotropic wet etching 
From the 1950s to the present, for isotropic wet etching, a mixture of hydrofluoric acid, 
nitric acid, and acetic acid (HF/HNO3/CH3 COOH) is the most common etchant 
solvent used to thin down the silicon wafer. The etch rate is determined by the 
concentration of each etchant. Isotropic etching of silicon using HF/HNO3/CH3 COOH 
(various different formulations have been used) is still frequently used to thin down 
the silicon wafer. The etch mechanism for this combination has been elucidated and 
is as follows: silicon oxidization is done by HNO3, which is subsequently dissolved 
away in the HF. The etch works as well without the acetic acid. For short etch times, 
silicon dioxide is usually used as a masking material against HNA (hydrofluoric, 
nitric, acetic) but for longer etch time silicon nitride is preferred. As the reaction takes 
place, the material is removed laterally at a rate similar to the speed of etching 
downward. This lateral and downward etching process takes places even with 
isotropic dry etching which is described in the dry etch section. 
The reaction can be broken down into two simultaneous steps: (1) oxidation of silicon 
into silicon dioxide (SiO2) by HNO3 (Eq. (3.1)) and (2) SiO2 removal using HF (Eq. 
(3.2)). In Eq. (3.3), the overall reaction is given. The important factor is here that the 
etching rate is limited by the rate of oxide removal. The rate-limiting factor will be the 
HF diffusion to the silicon surface which will result in more faster etching (shrinking) 
of the pillar top. 
3Si + 4HNO3 = 3SiO2 + 4NO + 2H2O Eq. (3.1) 
SiO2 + 6HF = H2SiF6 + 2H2O Eq. (3.2) 




 Two terms were introduced in 2010 on a wafer-scale etching technique based on R. 
Bhandari’s research: (1) dynamic (with stirring) and (2) static etching(without stirring) 
[34]. Fig 3.8 illustrates the combination of etching progression with dynamic and static 
etching. Based on the abovementioned theories, in this work, to sharpen silicon pillars 
into a sharp needle-shaped profile a static wet etching system made up of the mixed 
solution HF (49%)–HNO3 (69%) in a ratio of 1:19 by volume was utilized. 
Figure 3.7 Curves of constant etch rate of silicon (mils/min) as a function of etchant 
composition in the system 49.25% HF, 69.51% HNO3, and diluent [34]. 
 
Fig 3.7 demonstrates the observed geometry effects on the initially rectangular 
parallelepipeds. We can see that the geometry of the etched 25% HNO3 on this axis, 
the geometry becomes square and the surface has a matte appearance. Further 
increase of HNO3 above 35% is accompanied by progressive rounding of the corners 








Figure 3.8 SEM images showing progress of needle formation from dicing through 
etching (a–f). The rectangular microneedless (a) are transformed into sharp needle shapes (d) 
during static etching (8min). The change in geometry is observed due to the high etch rate (20 
μm/min) [35]. 
Underetching remains a problem in isotropic etching in the fabrication of precise 
lateral structures. The isotropic etch front has almost a spherical form if the etch 
solution is well stirred. While fabricating a microchannel with isotropic etching, the 




considered. But the major advantages of wet etching are high selectivity, a relatively 
planar etching surface, and the controllable etch rate. For removing thin layers 
isotropic wet etching is often used. Well-stirred etch solution is necessary for this 
process because of the possible bubble formation on the etched front. In table 3.1 some 
common recipes for isotropic wet etching are listed. 
Table 3.1 Common recipes for isotropic wet etching 
3.2.1.2  Anisotropic wet etching 
In semiconductor manufacturing processes, anisotropic etching is preferable. As 
mentioned before, most wet etching profiles are isotropic but an exception is seen for 
etching crystalline materials, whereas etching profiles of dry etching are anisotropic. 
Anisotropic etching of silicon is typically accomplished by KOH. Crystalline 
orientation determines the etch rate of KOH in single-crystalline silicon. The <111> 
plane of the silicon crystal has two orders of magnitude slower etch rate than the <100> 
plane; so, the <111> plane defines the single-crystalline structures etched in KOH. For 
this reason, the etching process in KOH is also called anisotropic etching. Since this 
innovation is a wet-etching process, the equipment is straightforward and simple 
.Anisotropic etching in KOH is not compatible with standard CMOS processes 
because of the fact that KOH is a source of mobile ion contamination. By using a 
barrier layer or a metal-ion free etchant such as Tetramethylammonium hydroxide 
(TMAH) the problem of metal ions can be mitigated. For precise fabrication with 
anisotropic wet etching, controlled etch stop plays an important role. Different 
methods to reduce the etch rate are:  
Materials Etchants  Selective to 
Si HF/HNO3/CH3COOH SiO2, Si3N4 
Si KOH SiO2,  Si3N4 
SiO2 NHF4, HF Si 
SiO2 HF, H2O Si 
Si3N4 H3PO4 SiO2 




(a) Silicon surface can be coated with a protective layer such as nitride or oxide; 
(b) The dependence of etch rate on orientation; and 
(c) Controlled hole generation. 
 Polycrystalline materials like silicon shows usually anisotropic etching because an 
etch rate selectivity 400 times higher in the <100> crystal direction than in the <111> 
direction is shown using etchants like potassium hydroxide (KOH). An anisotropic 
wet etch on a silicon wafer creates a cavity with a trapezoidal cross-section. The 
bottom of the cavity is a <100> plane, and the sides are <111> planes, see Fig. 3.9 [32]  
Figure 3.9 Anisotropic wet etch on Si wafer. The blue material is an etch mask, and the 
green material is silicon [32]. 
By using KOH wet etching technology, silicon microneedle structures with high 
accuracy and good reproducibility can be fabricated based on the etching rate ratio 
between the crystal planes in the silicon lattice. In 2005, a research group in Tyndall 
National Institute produced a systematic method of microneedle manufacturing with 
well-defined structures [33]. The process flow chart starting from a standard, P-type, 
bare silicon wafer with orientation of (100) is shown in Fig. 3.10. As it is shown, via 
wet etching process, the exploitation of silicon microstructures with high index crystal 
planes forming microneedle shapes is done by using 29% KOH and a temperature of 
79 °C. In step 3 the illustration of the formation of (111) silicon crystal planes are 
visible. With an octagon at the base, (111) crystal planes are etched away by faster 




defined by the eight high index crystal planes, defined as (312) planes [33]. Fig 3.11 
illustrates the result of one single microneedle shape with a height of 280 μm. 
Figure 3.10 Simple wet etch process flow [33] 
Figure 3.11 SEM picture of a single microneedle: side view with detail of negative slope 
etch (left); side view (middle); top view (right) [33]. 
3.2.2 Dry etch 
Dry etching was first introduced in late 1970’s and is one of the most widely used 
processes in today’s semiconductor manufacturing because it is easier to control, is 
capable of defining feature sizes smaller than 100 nm, and it is capable of producing 




chemical reactions, by purely physical methods, or with a combination of both 
chemical reaction and physical bombardment. 
Plasma may be a totally or partly ionized gas composed of equal numbers of positive 
and negative charges, in addition to some neutral molecules. By applying a strong 
radio frequency electromagnetic field to a gas, plasma can be created, which will break 
down gas molecules and generates ions, free radicals, electrons, photons and reaction 
by-products such as ozone. These reactive species have high energy so they create 
highly active and low-temperature plasma which is used to etch materials precisely 
and efficiently. A simple representation of how plasma interacts with silicon substrate 
is shown in Fig 3.12.  
Figure 3.12 Interaction between plasma and silicon atom 
Dry etching has many advantages when compared with wet etching. These include 
higher anisotropy and smaller undercut. However, the selectivity of dry etching 
techniques is poorer than that of wet etchants, and one must take into account the 
finite etch rate of the masking materials. There are mainly three basic dry etching 
techniques, namely high-pressure plasma etching, reactive-ion etching (RIE), and ion 
milling, utilize different mechanisms to obtain directionality. 
The three basic dry plasma etching techniques are depicted in Fig 3.13. It shows 
plasma gives rise to isotropic profiles, high etch rates and high selectivity, but ion 
milling presents positively tapered profiles, low selectivity and low etch rates, 




combination of physical sputtering with chemical activity of reactive species with high 
etch rate and high selectivity [35]. 
Figure 3.13 Typical etching profiles of the three basic mechanisms of dry plasma etching. 
(a) plasma etching (b) reactive ion etching (RIE) and (c) Ion milling. (Courtesy to H. Jansen, 
H. Gardeniers, etc.) 
If the etching relies only on ion bombardment, it becomes very time consuming and 
inefficient. Thus reactive ion etching (RIE) has been considered one of the most diverse 
and most widely used processes in industry and research. The process is much faster 
since the process combines both physical and chemical interactions. In Fig 3.14, we 
can see the comparison between the etch rates with or without the aid of Ar ion beam. 
By pure chemical or physical dry etch alone, very slow etch rate is achieved whereas 




Figure 3.14 Etch rates of silicon as only XeF2 gas, only Ar ion beam, and combination of 
them are introduced to the silicon surface. Ion-assisted chemical etch increases the efficiency 
of the etching. 
In RIE, several gases are introduced inside a reactor where the substrate is placed. 
Using an RF power source, a plasma is struck in the gas mixture which breaks the gas 
molecules into ions. This is illustrated in Fig 3.15. In the chemical part of reactive ion 
etching, the free radicals are accelerated towards, and reacts at, the surface of the 
material being etched, forming another gaseous material. The physical part which is 
similar in nature to the sputtering deposition process is also important. If the ions gain 
high enough energy, without the help of chemical reaction, they can knock atoms out 
of the material to be etched. To balance the chemical and physical etching, the 
development of a dry etch process is a very complex task. Anisotropy can be 
influenced by changing the balance since the chemical part is isotropic and the 
physical part is highly anisotropic; the combination can form sidewalls that have 
shapes from rounded to vertical. In some cases, the sample chuck temperature is 
deliberately elevated to boost volatility of the product. A schematic of a typical 
reactive ion etching is shown in the Fig 3.16.  





Figure 3.16 Simple RIE process [35]. 
One advantage of RIE system is that reasonably safe gases can be supplied into the 
chamber. CF4 is an example of this. In plasma this gas can generate many F atoms (free 
radicals) and these free radicals are extremely reactive and spontaneously attack 
silicon and produce SiF4. However, this gas shows fairly inert nature under normal 
conditions. In such plasma reaction, silicon will be readily turned to SiF4. In addition, 
ions in the plasma will bombard the cathode similar to sputtering. This action creates 
an additional source of energy that can accelerate the etch rate parallel to the ion 
trajectories. Because ions are directed at normal incidence to the cathode, this has the 
effect of accelerating the etch rate normal to the substrate. This will result in an etch 
profile that has minimal undercut and is strongly anisotropic. Different reaction steps 
of RIE for Si etching by using CF4 is shown in Fig 3.17 [35]. 
Figure 3.17 Reaction steps of RIE using CF4 for Si etching [35]. 
Using RIE technique, the directionality of the ion’s velocity produces much more 




rates in the vertical direction. In some cases, side-wall passivation methods are used 
to increase the etch anisotropy further.  
In mid-90’s, SF6/CHF3/O2 based silicon etching systems were most popular options for 
anisotropic silicon etching. However, by 2000’s a new deep silicon etching technique 
was developed by researchers at Robert Bosch GmbH, currently known as Bosch 
Process which is capable of achieving aspect ratios of 30:1 and silicon etching rates of 
10 – 20μm/min and using this technique through wafer etch is also possible.  
In this technique, the passivation deposition and etching steps are performed 
sequencially in a two-step cycle, as shown in Fig 3.18 [37,38]. SF6/Ar is typically used 
for the etching step and a combination of Ar and a fluoropolymer (nCF2) for the 
passivation step is used in commercial silicon DRIE etchers. With a typical thickness 
about 50 nm, a Teflon-like polymer is deposited during the latter step, covering only 
the side-walls where Ar+ ion bombardment removes the Teflon on the horizontal 
surface. Because of the cyclic nature of this method, the side-walls of the etched 
structures exhibit a periodic wave-shaped roughness of 50 – 400 nm. Fi 3.19 shows 
some micro/nano structures with high aspect ratio etched using DRIE process [39]. 





Figure 3.19 High aspect ratio micro/nano structures using DRIE process [39]. 
To sum up wet etch can be easily implemented in the experiment with quick reaction, 
but it is quite a difficult task to control and define the precise feature sizes that are 
smaller than 1 μm. Alternatively, dry etch like DRIE process itself is an established 
approach to create structures (pillars and holes in our work) with fairly high aspect 
ratio. But it is a major challenge to develop an optimized recipe for etching of 















Overview of Microneedles 
As a conventional drug delivery method, oral administration of drugs was considered 
in the past, but gradually some downsides came out because such techniques are often 
not applicable for new protein based, DNA-based, and other therapeutic compounds 
produced by modern biotechnology [40-42]. For the patients who have needle phobia, 
also to reduce hypersensitivity, bruising, discomfort and bleeding at the site of 
administration, applying transdermal patches to deliver drugs across the skin became 
an attractive approach. However, delivery of active pharmaceutical ingredients 
through transdermal route is severely restricted and hindered due to low permeability 
and the excellent barrier properties of the stratum corneum of the skin as we discussed 
in chapter one [43-44].  
Disrupting the barrier properties and increasing the permeability of the stratum 
corneum is one of the techniques utilized in enhancing transdermal drug delivery. 
With this intention, the idea of combining the benefits of needle injection and 
transdermal patches is brought out. Microneedles are generally hundreds of microns 
long, few to tens of microns wide at the tip, and on the order of 100 μm wide at the 
base and they can painlessly penetrate the SC and create micropores through which 
drug molecules can readily permeate, and they can also collect sample of interstitial 
fluid painlessly. Even though the concept of microneedles was first introduced in 
1976, it was not possible to make such micron-sized medical devices until the first 
exploitation of microelectromechanical systems (MEMS) for this purpose in 1998 [45]. 







4.1 Types of microneedles and applications 
A microneedle is a needle with delicate parts on the micrometer length scale. In spite 
of the fact that there are numerous instances of "microneedles" with lengths of a couple 
of millimeters, a typical comprehension of microneedles is that the length of the needle 
is shorter than 1 mm. What can be said is that microneedles are altogether smaller than 
normal needles, particularly concerning the length. A classification for microneedles 
usually used in literature is based on the fabrication process: in-plane or out-of-plane 
microneedles. In-plane needles are arranged along the plane of the substrate while 
out-of-plane needles are arranged perpendicular to the plane of the substrate. Fig 4.1 
shows the comparison between the orientation of in-plane and out-of-plane 
microneedles [28].  
Figure 4.1 Orientation of In-plane and Out-of-plane microneedles [28]. 
Microneedles can be divided into two major categories which are; solid and hollow. 
Different materials can be used to fabricate each of these and they can be applied to 
different functionality depending on their designs.  
4.2 Solid microneedles 
Solid microneedles are usually much stronger, sharper and easier to fabricate than 
hollow microneedles [16]. They are effective for drug transport because of their 
mechanical strength and sharper tip [46]. For delivering a variety of substances such 
as 5-aminolevulinic acid, Insulin, DNA, and vitamins solid microneedles have been 




4.2.1  Silicon solid microneedle structures 
Silicon was used as the first material to fabricate solid microneedles for pre-treatment 
of skin prior to patch application [48]. In 1998 Henry showed that silicon microneedles 
were able to increase skin permeability to Calcein by up to 3 orders of magnitude 
when compared to diffusion of Calcein through intact skin. In these experiments, 
silicon microneedles were inserted into the human skin obtained from autopsy; using 
a Franz diffusion cell, the group measured the permeability of Calcein through the 
epidermis for instances where the skin was first pre-treated with microneedles and 
compared this with the permeability of Calcein through intact skin without 
microneedles inserted. In terms of increasing the transport of drugs through the skin 
by a great extent, this experiment proved this technique to be effective (Fig 4.2) [48].  
Figure 4.2 Permeability of drug through skin with no microneedles inserted, 
microneedles inserted and remained inserted during topical application of drug, 
microneedles inserted then removed after 10 seconds, and microneedles inserted then 




An out-of-plane silicon needle array featuring 100 μm diameter, 1.5 mm long needles 
on an area of 4.2 mm × 4.2 mm was one of the earliest stated microneedles in the 
scientific literature (Fig 4.3) [49]. These needles are used as electrical electrodes and 
designed to stimulate the visual cortex of the brain in order to regain sight because of 
their extreme slenderness. Associated to this application, in-plane microneedle probes 
are now used for activity recording and cellular chemostimuli of brain tissue [50,51]. 
Solid out-of-plane microneedles have been used to penetrate the stratum corneum to 
facilitate EEG (Electroencephalogram) measurements for anesthesia monitoring 
[52,53].  
Figure 4.3 (a) 6 mm long, hollow, in-plane microneedle [54]. (b) Individually addressable, 
1.5 mm long, solid, out-of-plane microneedles used as electrodes [49]. 
Another example of solid microneedle using silicon is shown in Fig 4.4 [55]  
Figure 4.4 Silicon microneedle array used for gene delivery in skin [55]. 




Because of the brittleness and cost of silicon [56], as alternative to silicon solid 
microneedles have been fabricated out of different polymer materials. Another 
advantage of polymer microneedles is its biodegradable nature. Compared to silicon, 
polymer is a cheaper, and embossing for mass production has been proposed for 
obtaining polymer microneedle structures [57]. Various types of biocompatible 
polymers such a poly-glycolic acid (PGA) [58] and polycarbonate (PC) [59] have been 
used to fabricate microneedles. Jung-Hwan Park and his research group presented 
PDMS micromolding technique to fabricate an array of 200 PGA solid microneedles 
in 2007 [60-61]. Microneedle master structures were fabricated using microlenses 
etched into a glass substrate that focused light through SU-8 negative resist to produce 
sharply tapered structures [61]. Fig 4.5 (a) shows the results after replicating SU-8 
master structures using PDMS micromolding technique. 
Figure 4.5 Tapered solid microneedles made of PGA [61]. 
In contrast, polymers are limited by their mechanical properties. The tips of 
microneedles fabricated using polymers are inevitably blunt due to the low modulus 
and yield strength of polymers [62]. Using biodegradable polymers, beveled tip and 
tapered microneedles have been fabricated (Fig 4.6) [63]. As the main material for the 
fabrication of many polymer microneedles, polyglycolic acid (PGA) has been chosen 




Moreover, the viscoelastic property of polymers may allow more mechanical 
flexibility of the materials, thus reducing chances of damage during handling [65]. 
Figure 4.6 Biodegradable microneedles (beveled microneedles inserted through human 
epidermal tissue in vitro). The needles are approximately 400 μm long [63]. 
4.2.3 Metal solid microneedles 
In transdermal drug delivery application, microneedles fabricated out of metal are 
commonly used which can be for example steel [66] or titanium [67] using the poke 
with patch method. For example, using the poke with patch method, Martanto et al 
(2004) have used laser-cut steel microneedles for transdermal insulin delivery. The 
blood glucose level in the diabetic rats was observed to have decreased by as much as 
80% following Insulin delivery using microneedles. Fig 4.7 shows the comparison 
between the results obtained for blood glucose levels after microneedle and 




Figure 4.7 Changes in blood glucose level of hairless rat after Insulin delivery via different 
routes. Dark triangles indicate microneedle delivery while the X indicates delivery across 
untreated skin. Other symbols indicate delivery using hypodermic needles [68]. 
Many companies now fabricate solid metal microneedles array. An example of solid 
stainless microneedles is shown in Fig 4.8. 
Figure 4.8 Stainless steel microneedle arrays SEM micrograph of a sharp stainless steel 
microneedle (source: https://micropoint-tech.com/technology-of-micropoint/) 
4.3 Hollow microneedles 
Hollow microneedles are generally used for fluid infusion of liquid drug and 




are less widely used. But less expensive methods of fabricating hollow microneedles 
are evolving [69].  
Despite the advanced fabrication strategies needed to get them, hollow microneedles 
need simpler formulations without the necessity to formulate a coating method. 
Hollow microneedles were used into inject Insulin to hairless rat skins [70]. Although 
hollow microneedles are more prone to fracture on insertion to skin than solid 
microneedles, they pose the advantage over most solid microneedles of being able to 
provide continuous infusion into the skin. Furthermore, there have been some efforts 
to resolve the limitations associated with infusion using hollow microneedles such as 
blockage of the tip while inserted in the skin. Side opened hollow microneedles has 
been designed and fabricated to address the decreased infusion rate caused by a 
blockage at the microneedle tip [71]. Fabrication of pocketed microneedles as an 
intermediate between hollow and solid microneedles can be used to provide 
nanoparticles and larger solids into the skin [72]. Hollow microneedles can be 
fabricated out of silicon, metal as well as polymer materials.  
4.3.1 Silicon hollow microneedles 
In 1999, the first hollow out-of-plane microneedles were produced [73]. Because of 
their mechanical properties and their biocompatibility potential, silicon microneedles 
are justified. Fig 4.9 shows that 150 μm long hollow silicon microneedles can be 
fabricated by combining the fabrication process of solid silicon microneedles with 
DRIE Bosch process to create a hollow shell structures with high aspect ratio, and 




Figure 4.9 The circular side-opened design developed [73]. (a) 400 μm long, ultra-sharp, 
side-opened microneedles. (b) Magnified view of the microneedle tip. The tip-radius is below 
100nm [75] 
Clogging issue must be considered discreetly once the microneedles were tested on 
human, no matter for drug delivery or biofluid extraction. To avoid the clogging a 
method was developed using side-opened microneedles [79]. By combining 
anisotropic DRIE and isotropic dry etching of silicon, a three-dimensional needle 
structure was formed that intersects with the needle bore at the shaft of the needle (Fig 
4.10). The 210 μm needles have a relatively low fluidic resistance and were capable of 
penetrating aluminum foil without being damaged.  
Figure 4.10 Cross-shaped, hollow, side-opened, silicon microneedles (a) Needles with a 50 
μm long base shaft. (b) Needles without a base shaft [79]. 
In 2003, an approach to fabricate tetrahedrally-shaped hollow microneedles in silicon 




advantage of such approach is that the needles become really sharp as a result of 
intersecting crystal planes while the tetrahedral shape ensures mechanical robustness.  
Figure 4.11 350 μm long silicon microneedle etched by combining DRIE and wet etching 
[80]. 
Another type of hollow silicon microneedles was presented in 2000 [76-77]. Using 
DRIE the fabrication of about 200 μm long needles starts by etching the needle bores 
from the backside of the silicon wafer. The front side of the wafer was etched by 
isotropic dry etching (Fig 4.12). In a later study, the needles were tested by delivery of 
methyl nicotinate (a vasodilating agent) into human subjects [78]. On a standard 1 ml 
syringe, microneedle array chips containing a few needles were mounted and pressed 
against the subject’s volar forearm while injecting. It was estimated that nearly 1 μl 




Figure 4.12 Hollow silicon microneedles. (a) Pointed tip. (b) Flat tip [78]. 
4.3.2 Metal hollow microneedles 
Metal hollow microneedle patches are typically produced by forming microneedle-
shaped cavities using polymer followed by electro-deposition of metal on top of them 
[81-85]. Fig 4.13 (a,b) shows the SEM images of the first metallic hollow microneedle 
manufactured in 1999 [83]. According to the research, skin permeability increased up 
to 100,000-fold by hollow microneedles.  
Figure 4.13 Nickel hollow microneedles: (a) hollow microneedles with blunt tip [82] (b) 
hollow microneedles with sharp tip [83] (c) hollow microneedle formed by electrodeposition 
of metal onto a polymer mold used for needle insertion and fracture force measurements [84]. 
An SEM image of the 37 hollow microneedle array fabricated with NiFe, alongside a 26-gauge 
hypodermic needle is shown in Fig 4.14 (a). The fabrication method for the hollow 
microneedle array involved creating solid microneedles first using the silicon RIE technique, 
and creating a female-mold for silicon solid microneedles using SU-8 photoresist, followed by 
electro-deposition of NiFe [81]. Using the fabricated hollow microneedles, skin permeability 




Figure 4.14 NiFe hollow microneedles (a) array of tapered metal microneedles shown next 
to the tip of a 26-gauge hypodermic needle, (b) a single tapered metal microneedle made by 
electro-deposition onto a polymeric mold [81]. 
4.3.3 Polymer hollow microneedles 
A similar microneedle design to the Fig 4.15 was presented by Moon and Lee [86]. But 
instead of silicon, the needles were fabricated in polymer PMMA (polymethyl 
methacrylate) using LIGA-techniques with inclined x-ray exposure (Fig 4.15) [87]. The 
noticeable fact was that 900 μm needles were demonstrated to cause bleeding after 
insertion to the back of a human hand while insertion into a fingertip did not cause 




Figure 4.15 Microneedles made in PMMA using LIGA techniques [86].  
Figure 4.16 A 16 hollow microneedle array moulded in highly biocompatible polymeric 
material [88]. 
To prevent the phenomenon called the “bed of nails” effect which, due to the elastic 
response of skin, may prevent correct microneedles insertion, a proof-of-concept 
microneedle array (Fig 4.16) has been designed and optimized taking into account 
mechanical resistance and fluid flow [89]. 
The challenge for designing and fabricating hollow polymer microneedle systems 
often resides in the fact that they should be practical in a wide range of applications 
and they must be optimized in terms of mechanics and fluid dynamics, as well as 
being cost-competitive with traditional hypodermic injections. Volume of injection, 
injection time, needle resistance, and, most of all, production costs are the main 
problems encountered in designing microneedle solutions. 
4.4 Other microneedle devices 
4.4.1 Coated microneedles 
Microneedles coated with different drug substance are applied to the skin in a 
technique also referred to as the ‘coat and poke’ approach. This process involves 
coating the drug to be delivered around the surface of the microneedle. The drug 




into the blood capillaries upon inserting the microneedles through the skin [90]. There 
are different coating methods available such as roll coating, spray coating, and dip 
coating. Gill and Prausnitz proposed a novel dip coating method suitable for efficient 
coating at the micron scale in 2006 [90]. Metal and silicon both can be used to fabricate 
coated microneedles. The dip coating method has also been used in a number of other 
experiments, for example Jiang used the dip coating method to coat drugs unto metal 
microneedles to insert into human cadaveric sclera tissue [91].  
A commercially developed coated metal microneedle device is the Microflux 
microneedle patch [92] which comprises an array of 190 or 321 microneedles on a 1 or 
2 cm2 base plate and they are usually 330 or 200 μm long with a thickness of 35 μm 
and  170 μm (Fig 4.17). 







4.4.2 Self-dissolving microneedles 
Dissolving microneedles are made of a soluble/biodegradable material with the drugs 
encapsulated within the microneedle structure. To produce this type of microneedle, 
micromolding techniques are used [93]. After the insertion, the needle matrices 
dissolve in the skin and release their cargoes (Fig 4.18) [93,94,43]. Generally, these 
types of arrays are made of sugars, carbohydrates or synthetic polymers [93], and have 
been utilized to deliver a range of different substances including insulin [95,96], low 
molecular weight heparin [97], ovalbumin [98], adenovirus vector [99], vaccine 
antigens [99], in addition to low molecular weight drugs. Dissolving microneedles 
have also been used successfully in combination with other permeation enhancing 
strategies such as iontophoresis [100]. 
Figure 4.18 Simple schematic of the mechanism of self-dissolving microneedles [102]. 
Usually high temperature is needed to fabricate polymer microneedles and  
sometimes encapsulating microneedles use a non-biocompatible polymer. Other 
studies have designed novel methods for making dissolving microneedles that do not 
require such high temperatures and allow for the delivery of sensitive molecules such 
as protein. An example of the dissolving microneedles fabricated by the group Lee et 




Figure 4.19 Dissolving microneedles containing bovine Serum albumin [103]. 
4.5 Conclusion 
In the first place, as the field has turned out to be progressively developed, more 
applicable and sufficient trial assessments are being performed, incorporating into 
vivo preliminaries. Second, the lengths of the needles are becoming longer. Third, the 
material choice is increasingly broad and polymer needles are gaining more ground.  
A compact applicator or a special insertion device is used to achieve skin penetration 
by several groups. While hollow microneedles have turned out to be more desirable 
in late years for providing a better alternative in both the delivery quantity and more 
controllable flow rate, some research groups effectively work and produce different 










Methods and Fabrication of Microneedles 
 
5.1 Chip design for out-of-plane microneedles 
The objective of the process is to make a hollow silicon out-of-plane needle-shape 
array for ISF extraction in an innovative double-side DRIE approach and etch the tip 
using wet and dry etching processes. We followed some basic logic for our process 
and they are as follows: defining the bore-hole structure on one side of wafer and 
pillar structure on the other side of the wafer; afterward, sharpen the pillars into 
needles using wet and dry etching while exposing the bore-holes at the same time 
using wet etching. Hence, our process includes three vital steps: lithography, DRIE, 
wet and dry etching. The backgrounds of these techniques have been introduced and 
discussed in Chapter 3. In Mukerjee’s paper three different designs for the 
microneedle tip shape were investigated, termed as ‘volcano-like’, ‘micro-
hypodermic’ and ‘snake-fang’ design [18]. The relative position of the central bore 
hole to the shaft of the needle is the only difference visible between them. Three 
different microneedle shape fashions designed by Mukerjee is shown in Fig 5.1. The 
silicon walls at the tip seem relatively fragile and ISF extraction can be hindered by 
the blockage of the centered bore with tissue upon infiltration into the skin in ‘volcano-
like’ design. In comparison with ‘volcano-like’ design, ‘micro-hypodermic’ design 
shows robustness in the microneedles to penetrate skin without any breakage. 
However, bore hole plugging was one of the problem with this design. Therefore, our 
out-of-plane microneedle array was designed based on the ‘snake-fang’ fashion, as 
shown in Fig 5.2. The enhancement of skin penetration can be obtained by peripheral 





Figure 5.1 SEM pictures of three different designs (a) ‘volcano-like’, (b) ‘micro-
hypodermic’, and (c)‘snake-fang’[18]. 
Figure 5.2 The design of hollow microneedle array. (a) 200 μm in diameter pillars and 40 
μm in diameter holes with 76 holes per die. (b) 30 μm offset from the central bore hole to the 
center of the pillar. 
5.2 Fabrication process 
The proposed fabrication process for hollow out-of-plane silicon microneedles is 
illustrated in Fig 5.3. With about a thickness of 10 μm, a single layer of AZ 4620 
photoresist was spun onto one side of a 4-inch silicon (double-side polished) wafer 
which we term as the ‘backside’. In Fig 5.3(b), to pattern the hole structures that are 
approximately 30 μm in diameter on the photoresist, a standard photolithography 
was performed. Using Bosch Process (DRIE) bore holes about 300 μm deep into the 
backside of the wafer defining a fairly high aspect ratio (HAR) structure (around 1:10) 
was etched (Fig 5.3 (c)). Note that at this moment the other side of the wafer termed 
as ‘frontside’ is still flat. The DRIE process was stopped before the bore-holes were 




pattern was defined similar to the backside patterning, with the double-sided 
alignment to the holes on the backside. Again the AZ4620 photoresist was spun and 
patterned to create cylindrical pillars aligned to the bore-holes. This alignment also 
enabled accurate patterning of holes such that their centers were offset with the circles 
that defined needle. This was to address tissue coring within the needle bore during 
insertion [18]. Using DRIE pillars of approximately 300 μm in height and 200 μm in 
diameter were then etched (Fig 5.3(e)), maintaining an overlap of 100 μm between the 
pillars and holes. At this point, the bore-holes were still not exposed on the frontside; 
essentially they are still buried channels. Afterwards, using a mixed solution of 
hydrofluoric acid and nitric acid (wet etch), the circular pillars were sharpened into 
needles and the through wafer holes were fully opened (Fig 5.3(f) and 5.3 (g)). Taking 
the advantage of the isotropic etching nature of the chemical mixture i.e., the etching 
rate decreases from the needle tip to the base, this was possible [34]. Holes were 
exposed on the side wall of the needles creating channels from the needles to the 
wafer’s backside. This final step is a critical and novel process for creating hollow 
microneedle structures. Dry etch i.e, SF6/O2 plasma was also performed to sharpen the 
needle tip. 
Figure 5.3 Schematic fabrication processing of hollow silicon microneedle arrays. (a) Spin 
coating on the backside, (b) Standard lithography, (c) DRIE on the backside, (d) Backside 






Before performing lithography, standard cleaning procedures for silicon wafers were 
done. Silicon wafers are cleaned by an HF (1:10) dip and DI water rinse, followed by 
acetone and isopropanol (IPA) rinsing and blow dry with a N2 gun. Oxygen plasma 
treatment can also be done prior to further processing to remove residue on the surface 
of a silicon wafer. Afterwards, to remove all moisture from the surface of the wafer, a 
soft bake (prebake) is done on the hot plate at 120°C for 3 minutes. The next step is to 
spin coat one layer of hexamethyldisilazane (HMDS) which increases the adhesion for 
the photoresist application after cooling down to room temperature. HMDS is spin 
coated at 3000 rpm for 30 seconds and it dries completely after the spin coating. The 
whole process requires about 30 minutes to complete. On the backside of a double-
side polished wafer, positive photoresist AZ4620 with a thickness about 10 μm was 
spun at 2000 rpm for 40 seconds followed by the standard photolithography. Fig 5.4 
(a-b) shows the hole and pillar pattern after lithography with HMDS coating prior to 
photoresist application, and without HMDS treatment, Fig 5.4(c) presents a poor result 
caused by spin coating photoresist.  
Figure 5.4 Importance of HMDS coating. The pattern is defined after standard 
lithography and development with and without HMDS coating. HMDS promotes the 
adhesion to define a better pattern. Structures migration on the wafer is visible if without 
HMDS application. (a) 30 μm in diameter holes, 300 μm pitch. (b) 200 μm diameter pillars. (c) 




For pillar structures, in the process of lithography, diameter with various sizes of 
pillars has been designed as shown in Fig 5.5.  
Figure 5.5 Pillars with different diameters. (a) 100 μm in diameter pillars. (b) 150 μm in 
diameter pillars. (c) 130 μm ID 270 μm OD. (d) 150 μm ID 270 μm OD 
The key step of the lithography process is the backside alignment which is to precisely 
placing the holes with different offsets relative to the center of the pillars. A detail on 
the alignment process is illustrated in Fig 5.6. Before the loading of the sample, the 
picture of mask aligner is taken as shown in Fig 5.6 (a), and then in Fig 5.6 (b), aligning 
the marks accurately is shown.  
Figure 5.6 Backside alignment process in Karl SUSS MA6. (a) only the captured pattern. 









There are two main technologies for high-rate DRIE: Cryogenic and Bosch-based DRIE [49]. 
But for production method, only the Bosch process is the vastly recognized [64]. Photoresist 
or other mask crack under extreme cold condition is the most essential limitation of cryo-
DRIE. Another associated issue is that the by-products have a tendency of depositing on the 
nearest cold surface such as the substrate and electrode [104-106]. There are many applications 
of DRIE but the major goals are usually in producing trenches or other features of very high 
aspect ratio [107]. 
5.2.2.1  DRIE on the backside 
In our research, the standard Bosch process recipe was modified and developed at the 
Quantum NanoFab at University of Waterloo for both our pillar and hole etching to 
achieve a high aspect ratio features. The etch rate is around 400 nm/cycle where each 
cycle is 12 seconds and uniformity is approximately 2%. Our target is to obtain around 
350 μm deep holes 30 μm in diameter and pillars with approximately 300 μm high 
and 100 μm in diameter. In our initial experiments, Bosch process was exploited with 
300 cycles to produce 110 μm deep holes with a vertical profile, but the diameter got 
enlarged from 30 μm to 50 μm. In Fig 5.7 (a), the cross-section view after 300 cycles of 
Bosch processing is shown and in Fig 5.7(b) the change in the diameter after DRIE is 
clearly visible.  
Figure 5.7 SEM results after 300 cycles of Bosch processing. (a) cross-section view. (b) top 




Later, additional 1500 cycles were done on the abovementioned samples. To create 
the holes to a depth of 400 μm, DRIE process of approximately 6 more hours were 
performed. A significant overcut was observed and the diameter was enlarged to 126 
μm. Fig 5.8 shows the results after the total 1800 cycles. 
Figure 5.8 The SEM picture after 1800 cycles of Bosch processing. (a) A cross-section view. 
(b) A zoomed-in view [108]. 
As shown in Fig 5.8, to form vertically deep holes 30 μm in diameter, profile and the 
diameter should be more efficiently controlled to form vertically deep holes 30 μm in 
diameter. Aspect ratio dependent etching (ARDE) is widely reported for deep silicon 
etching. An example of ARDE of trenches in varying widths is shown in Fig 5.9(a). Fig 
5.9(b) demonstrates the ARDE lag measured as trench depths are normalized to that 
of a 100-μm-wide trench [108]. The etch rate rapidly decreases with the aspect ratio; 
over a certain critical point of aspect ratio, the etch rate likely reaches a constant 
minimal value, all while the etch mask is continually consumed so leading to a lateral 
etching on the surface. Therefore, both enhancement of photoresist selectivity and 





Figure 5.9  (a) ARDE lag revealed in typical TDM plasma etch process. The final 
etch depths in wider trenches are larger. (b) A plot of trench depth normalized to that 
of a 100-μm-wide trench. Approximately 50% ARDE lag is presented in a 2.5-μm-wide 
trench [108]. 
The depassivation time and bias voltage should be respectively increased to remove 
the passivation polymer at the bottom of the holes by enhancing the ion bombardment 
to etch deeper holes with a vertically straight profile. At the University of Toronto, a 
DRIE machine which offers a high selectivity of up to 1:200, was used to optimize the 
recipe. In Fig 5.10 (a) the SEM result after etching with different optimized recipes is 
shown. By increasing the RF power, ramping the process pressure, and altering the 
length of Argon (Ar) bombardment time, we are able to produce holes approximately 
310 μm deep and 30 μm in diameter which is shown in Fig 5.10 (b); a top view of the 
holes after DRIE is illustrated in Fig 5.10 (c). There was no change in the diameter and 
it remained at 30 μm. Therefore, holes with approximately 310 μm deep and 30 μm in 
diameter can be obtained by an optimized recipe, consisting of increased RF power 
followed by a high aspect ratio etching recipe. Only 1 hour is needed for the whole 
recipe. Fig 5.10 [I] the result with an original Bosch recipe. A 214 μm deep hole with a 
critically vertical profile. By ramping the RF power from 100W to 120W, 243 μm deep 
holes can be achieved [II]. By adjusting Ar time from 700 ms to 800 ms, deeper holes 
with a 266 μm depth can be fabricated [III]. The best recipe is 500 cycles with 120W 




Figure 5.10(a) From left to right, SEM results are shown after 500 cycles etching. (b) a zoomed-
in view of the hole. (c) a top view of the holes. 
 
5.2.2.2  DRIE on the frontside 
On the contrary, more reliability is observed of DRIE on the frontside; due to low 
aspect ratio dependency, fabricating pillars approximately 330 μm tall, 200 μm in 
diameter was possible.  
Figure 5.11 SEM pictures after Bosch process etching. (a) 300 cycles. The pillar is ~100 μm 




To define a hollow needle structure, the combination of holes and pillars is the key 
step as we mentioned earlier in lithography paragraph (Fig 5.5). The perfect well-
aligned structure is formed on the backside via alignment lithography. In Fig 5.12, 
integration of holes and pillars after double-sided etching is shown. Another design 
is shown in Fig 5.13 where solid pillars are positioned between hollow pillars to 
enhance chip robustness and strength when the pillars are subsequently sharpened 
into needles and inserted into skin.  
 
Figure 5.12 The integration of holes and pillars. (a) misalignment between pillars ~80 μm 
in diameter and holes with 40 μm in diameter; (b) pillars well-aligned to bore holes. After the 








Figure 5.13 An array of hollow pillar structure. 300 μm is the center to center spacing. For 
ISF collection, 50% of the needles have bored holes, and the other half are solid to distribute 
the pressure in this particular design. 
 
5.2.3 Wet etch to sharpen the needle 
5.2.3.1  Solid microneedles 
In our work, to sharpen up the silicon pillar top to form a needle shape, a static wet 
etching involving a solution of HF (49%)–HNO3 (69%) mixed at a ratio of 1:19 by 
volume was set up. At the beginning, wet etching tests were done on solid pillars to 
obtain solid silicon needles. In Fig 5.14, pillars with 200 μm high and 100 μm in 
diameter is shown after acetone, IPA, photoresist stripper and oxygen plasma 




Figure 5.14 The SEM results of pillars after DRIE process. (a) Solid pillar array. (b) pillars 
with a zoomed-in view. 
After 20 minutes of wet etching, Fig 5.15 shows the SEM results where the tip diameter 
is approximately 60 μm while the base was measured to be approximately 90 μm in 
diameter. The pillar height is approximately 190 μm. We can conclude that the vertical 
shrinkage is much less than the lateral tip shrinkage while the etching rate decreases 
gradually from the needle tip to the base with this experiment.  
Figure 5.15 SEM images exhibit the blunt cone-shaped pillars. (a) high uniformity of the 




After that, another additional 20 minutes of wet etching was performed subsequently 
to make the top of the pillars sharper. SEM images of a very sharp solid microneedles 
array are shown in Fig 5.16. Upon performing this additional 20 minutes wet etching, 
the height of the pillar decreased from 200 μm to 150 μm, and concurrently the 
diameter at the base decreased from 100 μm to 70 μm while the dramatically 
decreasing of the tip radius to less than 5 μm is observed.  
Figure 5.16 SEM images after 20 minutes more wet etching. (a) high uniformity of a solid 
silicon microneedles array, and (b) an individual sharp needle in a zoomed-in view. 
If wet etching is performed for an excessive amount of time, over-etching will be 
present. Two types of over-etching are illustrated in the SEM images in Fig 5.17. 
Approximately 20 μm or in some cases less than 10 μm is decreased in the height of 
needles.  




5.2.3.1  Hollow microneedles 
After producing sharp solid microneedle array successfully, the next step was to 
obtain the hollow structure combining holes with needles. With different offsets 
relative to the center of the pillars, several hollow shapes can be achieved and ‘micro-
hypodermic’ and ‘snake-fang’ fashions were produced in our experiments (Fig 5.18).  
Figure 5.18  SEM images of two different hole offsets for producing the hollow Si 





While the bore hole in the ‘micro-hypodermic’ needle design is extended within the 
side of the needle, the potential of coring skin during ISF extraction may be present 
[18]. Therefore, an array of the ‘snake-fang’ design was fabricated. With different 
needle base diameters, Fig 5.19 (a-d) shows the ‘snake-fang’ hollow silicon 
microneedle array. Figure (e- f) exhibit a solid-hollow microneedle array and a needle 
height of approximately 300 μm, larger than that of Fig 5.19 (a)-(d).  
Figure 5.19 SEM images: (a-d) with different base diameter, the hollow silicon microneedle 
arrays (a) 200 μm high and 100 μm in diameter at the base; (b) a zoom-in view of image (a); 
(c) height is 200 μm and the base diameter is 60 μm; (d) a zoom-in view of image (c); (e-f) a 




holes, and the other half are solid to distribute the pressure upon skin insertion; (f) 300 μm 
high and 80 μm in diameter microneedles in a zoomed in view. 
5.2.4 Dry etch to sharpen the needle 
As we mentioned before, for the fabrication of micromechanical devices, dry 
anisotropic etching of silicon is an important technology. Due to its non-dependency 
on the crystal planes unlike wet etching e.g., KOH solutions, dry etch is performed in 
many cases. 
In our research, plasma etching was considered to minimize the vertical height loss 
for making taller needles. SF6 DRIE etching (isotropic) was performed at Quantum 
NanoFab at University of Waterloo (with the SF6 flow rate of 160 sccm and chamber 
pressure of 25 mTorr. The ICP power was kept at 1500 W with a 13.56 MHz frequency 
for both deposition and etching cycles; the RF bias power was kept at 20 W with a DC 
bias of 20 V for etching). In Fig 5.20 (a), an array of pillars with height of 300 μm 
aligned to holes of approximately 80 μm is shown. After performing 10 minutes of SF6 
dry etching on the above sample, the top of the pillar becomes sharper (2 μm/ min 
etching rate at the pillar bottom and base) and is shown in Fig 5.20 (b). 
Figure 5.20 An array of pillars with 300 μm high. (a) before dry etching. (c) after 10 minutes 
of dry etching. 
Another 10 minutes of dry etching is performed to the above sample and the top of 





due to the SF6 ion bombardment. Fig 5.21 shows the SEM results of the more 
sharpened needle tip (a) and some top part removal due to the ion bombardment (b). 
A great uniformity is observed in this process.  
Figure 5.21 SEM images after total 20 minutes of SF6 dry etch. (a) the tip of the pillars was 
sharpened more. (b) a zoomed-in view to show the top part removal due to SF6 ion 
bombardment. 
Another SEM results show the shrinkage of the pillar part on the top after 30 minutes 
of SF6 dry etching process in Fig 5.22. Some of the pillars on the edge was broken due 
to ion bombardment.  
Figure 5.22 (a) an array of 200 μm high pillars before SF6 plasma etching. (b) after 30 
minutes of SF6 plasma etching. 
These are some interesting facts to consider while making sharper microneedles using 
SF6 plasma etching. Good results with respect to uniformity and reproducibility have 






and solvents, better process control and easy automation are some of the major 
advantages of using this technique to make the needle sharper. Further research is 
needed to improve the process and to achieve sharper needles without the damage. 
5.3 Chip design for in-plane microneedles 
Figure 5.23 Schematic diagram of (a) the in-plane microneedle chip and the zoom-in views 
of (b) needle tip and (c) microfluidic network and the reservoir. 
In Fig 5.23, the schematics of a silicon in-plane microneedle with open capillary 
microfluidic channels is shown. The needle with length of approximately 2 mm 
enables the penetration into elastic body tissues (e.g., skin) with sufficient insertion 
depth (Fig 5.24). Whereas the wedge squared shape of the needles (Fig 5.24a) can be 
fabricated with moderately simple processing, the large tip requires significant force 




Figure 5.24 Schematic diagram of a silicon in-plane microneedles with open capillary 
microfluidic channels (a) wedge-shaped needles and (b) sharpened-to-tip needles. 
Silicon wafers with the thickness of 500 μm were used for this work. With a pitch of 2 
mm, five microneedle arrays with 2 mm long needle shaft and base of 500 μm were 
integrated in each device. In the microneedle shaft the open trenches are embedded 
through which fluid will flow and enter the microfluidic channel network and end up 
in a reservoir on the backside of the device which is the opposite to the needle tips. 
Channel with a certain aspect ratio of depth to width is important for capillary 
drawing and it shows in the open channel design. Because of some processing 
constraints such that the trench width is designed as 10 μm, the trench depth is limited 
to 100 μm. Considering the length of few centimeters, the trench structure with very 
high aspect ratio may experience channel interruption triggered by some practical 
processing issues i.e, the coating of the resist, etching steps etc. To lessen the 
processing defects, the layout of multi-channels was designed. It also enables the 
elongating of the liquid-air meniscus of the capillary filling of the channels within the 
microfluidic network, hence making possible to recover more fluids. 





A silicon wafer with the <100> crystalline orientation was used to fabricate the 
microneedle pattern using standard photolithography techniques. First, the Si wafers 
are cleaned by immersion into hydrofluoric acid (HF: deionized water = 1:10) for 30 
seconds, followed by a solvent and deionized (DI) water rinsing, and a nitrogen blow 
drying. Immediately afterward, an adhesion promoter hexamethyldisilazane (HMDS) 
is spin-coated at 500 rpm for 30 seconds. Then to get a thickness of approximately 11 
μm, positive photoresist AZ 4620 is spin-coated at 2000 rpm for 40 seconds, followed 
by a pre-baking at 90oC for 5 minutes. To extend long etching through the silicon 
wafer, the photoresist coating can be repeated once again to make a 22 μm thick bi-
layered photoresist (termed as double layered resist). For the photoresist erosion 
under high bias power, ultrathick photoresist is required. The ultraviolet (UV) light 
exposure was carried out with a Heidelberg MLA150 maskless aligner operating at a 
dosage of 1000 mJ/cm2 for the single-layered resist and 1800 mJ/cm2 for the double-
layered resist. Then the exposed sample is immersed into a developer solution (AZ 
400k 4:1 developer). 
In our experiment, silicon samples were anisotropically etched in an Oxford 
Instruments PlasmaLab 100 inductively coupled plasma reactive ion etcher (ICP-RIE) 
380. The Si sample was attached on a 4 inch silicon carrier wafer using Fomblin oil as 
an thermally conductive adhesive. The deposition sub-cycle is 5 seconds long, with 
the C4F8 flow rate of 160 sccm (standard cubic centimeter per minute) and chamber 
pressure of 20 mTorr; the etching sub-cycle is 7 seconds long, with the SF6 flow rate of 
160 sccm and chamber pressure of 25 mTorr. The ICP power was kept at 1500 W with 
a 13.56 MHz frequency for both deposition and etching cycles; the RF bias power was 
kept at 20 W with a DC bias of 20 V for etching and at 5 W with a DC bias of 0 V for 
deposition. Moreover, the silicon etching processing can be modified as an isotropic 
etching to facilitate the needle sharpening process. This experiment utilized a 
continuous SF6 gas with the flow rate of 160 sccm and chamber pressure of 15 mTorr; 




was kept at 20 W with a DC bias of 150 V (± 10 V). Note that in all the above mentioned 
plasma etching process the continuous helium cooling was utilized to ensure the 
wafer temperature kept at 15 oC. The major process steps are illustrated schematically 
in Fig.5.25. In this study, the scanning electron microscopy (SEM) inspection was 
carried out using a Hitachi S-3000N SEM and Zeiss LEO 1530 FESEM.  
Aspect ratio dependent etching (ARDE) is widely reported for the deep silicon etching 
[108-110]. Aspect-ratio refers to the proportions of the depth and width of an etched 
object into the silicon wafer. The etching rate rapidly decreases with the aspect ratio 
of the etched structures. The mechanism probably lies that the ion flux down to the 
bottom of the structure decreased as the aspect-ratio of the structures (i.e., trenches) 
increases. Trenches with higher aspect ratio probably start to pinch-off at the bottom 
as a result of insufficient passivation layer removal; over a certain critical point of the 
aspect ratio, the etching rate would probably reach a constant extremely low value. In 
the simplest process design, the grove and wedge are patterned and etched at the same 
time using DRIE; but since the grove is very narrow, it etches much slower than the 
open area surrounding the wedge as a result of the aspect-ratio dependent etching 
process, such that when the wedge is fully etched through, the groove is etched only 
half way as desired [111]. 
The single-sided simultaneous etching of the needle shaft and open trenches is 
demonstrated in Fig 5.25 (a-c). First, a custom wafer polished for etching on both sides 
is spin-coated with photoresist on its backside. Photolithography is then applied to 
pattern this photoresist, allowing the DRIE process to etch 10 μm wide open trenches 
through the wafer from the backside (Fig. 4e). The DRIE is halted after the high aspect-
ratio trenches are etched (Fig 5.25f); the wafer’s front side is still flat at this point. The 
process is repeated for the frontside (Fig. 5.25g), but rather than trenches, the 
photoresist is patterned to create needle shaft aligned to overlap with the trenches (Fig 




utilized to sharpen the needle shaft structures in the presence of a sacrificial structure 
(Fig 5.25c) [34]. The isotropic “wet” etching to sharpen silicon structure uses the mixed 
solution of nitric acid (HNO3) and hydrofluoric acid (HF), at a volume ratio of 19:1, 
respectively. This etching chemistry is divided into two steps: first HNO3 oxidizes 
silicon into silicon dioxide (SiO2), then SiO2 is etched away by HF. It is important that 
the etch rate of silicon is limited to the rate of oxide removal. If so, HF diffusion to the 
silicon surface will be the rate-limiting factor, which will result in faster etching of the 
needle tip. A 30 minutes’ acetone soak was performed to clean the sample, following 
by a 10 min oxygen plasma treatment in a reactive-ion etching system (Phantom II, 
Trion Technology Inc.) to make the silicon sample hydrophilic. 
Figure 5.25 Schematic fabrication processing of silicon in-plane microneedle arrays (a-c) 






5.5 Results and discussion 
Using a standard Bosch process, the needle shaft and open trenches are 
simultaneously etched. To etch a 200 μm high needle shaft, with a straight and smooth 
sidewall profile, a 600 cycle of standard Bosch DRIE was performed (Fig 5.25 (a)). The 
microfluidic network with open trenches was simultaneously etched (Fig 5.25 (b)). A 
wedge-shaped needle rather than a needle with a pointed distal end was fabricated 
by DRIE. By immersing in an acetone soak for 30 min, the remaining photoresist was 
removed and then an oxygen plasma treatment was performed for 10 minutes prior 
to the isotropic etching process for sharpening. Afterwards, a SF6 plasma etching was 
done for 30 min, followed by 60 min of wet etching to sharpen the needle. The etch 
rate at the top is faster than that at the bottom, resulting in the sharpening of the 
needle. Note that due to the wet etching, the open trenches were damaged. 
Figure 5.26 SEM images of single-sided processed in-plane microneedles (a-b) before wet 
etching and (c-d) after wet etching. 
Further investigation was done for the etching of the microfluidic network, i.e., 
trenches and reservoirs (Fig 5.27). The three 10 μm wide trenches in parallel (> 1 cm in 
length) were patterned and etched by the standard Bosch process, half-way etching 




slightly smaller than that (i.e., 250 μm) of the open space between needles. By 
extending the etching to 1300 cycles, Bosch DRIE etched through wafer at the large 
space between needle shaft. However, the extended etching makes the narrow trench 
slightly deeper from 160 μm to 200 μm (Fig 5.26(c)and Fig 5.26(d)). The much slower 
etch rate within the high aspect ratio trenches is caused by the ARDE. The trenches at 
the needle tip were found to be deeper than that of the trenches in the silicon.  
The reservoir etching also takes advantage of the ARDE to slow down the etching rate 
at the large reservoir region (i.e., 500 μm × 2000 μm) for avoiding the through wafer 
etching. The ARDE is activated by utilizing the sacrificial structures, consisting of 20 
μm × 100 μm rectangular pillar arrays with a pitch of 20 μm (Fig 5.27(b), became (f) 
after etching). 
Figure 5.27 SEM images of the microfluidic channels from the single-sided processed 
microneedles: (a) trench and (b) reservoir from the half-way etching (600 cycles of Bosch 
processing); trenches and reservoir from the through-wafer etching (1300 cycles of Bosch 







5.5.1 Wet etching for needle sharpening 
Wet etching (mixture of HF and HNO3) was used to sharpen the needles. In this 
process, a kapton tape was used to attach the sample onto a clean silicon wafer. By 
dipping the device in static etchant for 30 min, the wedge-shaped needles were 
sharpened to a tip, with open trenches being intact (Fig 5.28(a). In Figure 5.28 (b), a 
zoom-in view of the needle end shows a tip less than 1 μm, smoothly tapering to the 
base. 
Figure 5.28 SEM images of (a) the sharpened microneedle shaft and (b) a zoom-in view of 
a needle tip. 
Sharpened microneedles are sufficiently robust to penetrate porcine and human skin. 
The platform enables the delivery of drugs to the target site of interest body tissues, 
and extraction of interstitial fluid (ISF) and blood in skin. 
 
5.6 In-Vivo tests using hollow out-of-plane microneedles 
An integrated system consisting of a microneedle arrays and reservoirs was 
developed. PDMS was cut out into desired dimensions with a reservoir facing the 
backside of the microneedle array. By using oxygen plasma cleaning and heating 

























Extraction tests with silicon hollow out-of-plane microneedles were performed on a 
living human arm. The tests were done in the following manner: by pushing on the 
device with thumb pressure on the center of the array and holding it for about 20 
minutes, the insertion of the microneedles was successfully performed; a syringe 
pump was set to withdraw fluid at a predetermined fluid extraction rate for a 
predetermined total volume immediately afterward; detach microneedle array from 
the skin by lifting directly outwards once the withdrawal process is complete. Fig 5.31 
shows SEM results of the microneedle array before and after extraction tests. 
Figure 5.31 An SEM image of the microneedle array before insertion (a). (b-c) The tissue 
and liquid residual on the needle. 
These tests presented above show some promising results. The highly impermeable 
outer-most layer of skin is penetrated by hollow silicon microneedle which can reach 
the epidermis layer in which ISF is located and extracted successfully inside the bore 











In today’s transdermal drug delivery research and development, microneedles are 
achieving noteworthy attention. By bypassing the skin’s outer layer of stratum 
corneum microneedles can also access biomarkers such as interstitial fluid (ISF) 
without interfering with the nerves in the deeper layer of skin which is very useful for 
painless sampling for various medical diagnosis. In our work, we have successfully 
fabricated out-of-plane and in-plane microneedles which can penetrate through the 
skin and extract interstitial fluid (ISF). These microneedle devices can be adapted to 
extract clinically relevant volumes of interstitial fluid through skin safely in a 
reproducible manner. 
This thesis presents the fabrication process of making out-of-plane and in-plane 
silicon microneedles robust enough to penetrate through the skin. This work 
demonstrates a novel double-side DRIE approach with modified recipe for producing 
hollow out-of-plane silicon microneedle arrays and the fabrication of silicon in-plane 
microneedles with microfluidic channels using also a novel double-side DRIE. While 
the out-of-plane silicon microneedles are sharpened by both wet and dry etching, the 
in-plane microneedles were etched by wet etching process alone. 
In our experiments, solid silicon out-of-plane microneedles were first fabricated with 
the tip radius approximately about less than 5 μm and wet etched on the frontside 
only. Using double sided polished silicon wafer, patterns of holes and pillars were 
designed on each side of the wafer and the etching from the both sides were integrated 
which results in the accomplishment of hollow silicon microneedles with two bore 
placements and this method was used to fabricate 200 μm and 300 μm high hollow 
silicon microneedles successfully and were sharpened by both wet etch and SF6 
plasma etch process. On the other hand, a standard bosch process was used to make 
2 mm long needle shaft with 500 μm base with multiple microfluidic channels in a 




were sharpened by using wet etching process while the microchannels were kept 
intact. 
Fascinating in-vivo tests were executed to extract ISF through skin using the hollow 
out-of-plane microneedles because such microneedles can only penetrate through the 
outer layer of skin without hitting the nerve system. In-plane microneedles were also 
robust and sharp enough to penetrate through the skin and can be used for drug 
delivery and extraction of biofluids for various purposes. 
Finally, comprehensive additional research and studies are necessary to optimize the 
extraction apparatus and to investigate the safety of these microneedles upon 
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